Identification of Diagnostic SNPs in Exon ۲۸ of the Von Willebrand Factor Gene for Diagnosis of VWD Type ۲B in Patients Referred to IBTO Coagulation Lab: In-silico Approach
سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 327
فایل این مقاله در 17 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_JIML-10-2_004
تاریخ نمایه سازی: 31 خرداد 1402
چکیده مقاله:
Background and Aims: von Willebrand disease (VWD) is brought on by hereditary impairments in the von Willebrand factor (VWF). It has been determined that most of the molecular abnormalities are present in exon ۲۸ of the VWF gene qualitative variations. In this regard, investigating mutations in exon ۲۸ of the VWF coding gene can help identify the VWD type and can be used to manage patients by using appropriate strategies.
Materials and Methods: ۱۰ suspected VWD type ۲B patients were investigated for the genotype of exon ۲۸. Routine coagulation tests were performed for the patients. Molecular sequencing was also used for the evaluation of mutations in exon ۲۸. Determining the tertiary structure of VWF can aid in understanding its functional residues and interactions. The nsSNVs’ pathogenicity was examined utilizing potent bioinformatics methods. Step-by-step testing of the high-risk mutations was done using SIFT, PolyPhen-۲, I-Mutant ۲.۰, PHD-SNPg, and SNPs&GO. Then, the secondary structure, amino acid conservation, and feature of amino acids were investigated via Protparam, Cofactor, Interprosurf, ConSurf, NetSurfP-۲.۰, and HOPE.
Results: N۱۲۳۱T, V۱۲۲۹G, V۱۳۱۶M, and P۱۲۶۶Q missense mutations in VWF were detected. ۳D structure of VWF predicted and evaluated. Putative conserved domains were identified. P۱۲۶۶Q and V۱۳۱۶M amino acid substitutions are predicted as “Not tolerated substitution” damaging and Disease, while V۱۲۲۹G and N۱۲۳۱T amino acid substitutions are predicted as “tolerated substitution” benign and Neutral.
Conclusion: V۱۳۱۶M and P۱۲۶۶Q amino acid substitutions were determined as high-risk mutations using powerful bioinformatics tools in VWD patients.
کلیدواژه ها:
نویسندگان
روشنک شمع ریز
International Campus, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
کامران عطاردی
Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
مینو احمدی نژاد
Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
نسرین قاسمی
Abortion Research Center, Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :